US Stock MarketDetailed Quotes

ELOX Eloxx Pharmaceuticals

Watchlist
  • 0.900
  • +0.062+7.44%
15min DelayClose May 17 16:00 ET
2.83MMarket Cap-101P/E (TTM)

Eloxx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.33%-3.45M
78.80%-2.07M
28.21%-6.81M
9.02%-31.85M
43.00%-5.66M
8.46%-6.95M
0.51%-9.75M
-23.50%-9.49M
-24.27%-35M
-112.75%-9.93M
Net income from continuing operations
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
70.55%-10.62M
-33.66%-11.62M
-92.98%-66.73M
-97.32%-12.09M
Operating gains losses
-890.00%-495K
103.85%4K
55.19%419K
109.87%45K
---71K
90.74%-50K
---104K
--270K
---456K
--0
Depreciation and amortization
-0.53%188K
42.31%185K
-6.06%186K
-27.60%695K
-11.88%178K
-32.26%189K
-60.73%130K
33.78%198K
68.13%960K
38.36%202K
Other non cash items
102.16%281K
-64.93%47K
-3.23%120K
-97.55%541K
18.03%144K
54.44%139K
-99.38%134K
12.73%124K
3,823.09%22.09M
-2.40%122K
Change In working capital
41.86%-250K
4,430.30%1.43M
-409.92%-1.91M
-268.75%-118K
-214.89%-270K
-276.23%-430K
-171.74%-33K
210.41%615K
99.06%-32K
352.69%235K
-Change in prepaid assets
-51.76%206K
-50.44%397K
50.64%-577K
-56.70%252K
493.88%193K
-40.28%427K
113.03%801K
-154.13%-1.17M
122.14%582K
-112.28%-49K
-Change in payables and accrued expense
59.77%-278K
265.62%1.21M
-158.96%-1.16M
13.49%244K
-164.76%-294K
-201.75%-691K
-1,522.22%-730K
5,497.14%1.96M
106.80%215K
225.41%454K
-Change in other current liabilities
-7.23%-178K
-70.19%-177K
0.57%-174K
25.93%-614K
0.59%-169K
31.40%-166K
63.51%-104K
-32.58%-175K
-65.14%-829K
-30.77%-170K
Cash from discontinued investing activities
Operating cash flow
50.33%-3.45M
78.80%-2.07M
28.21%-6.81M
9.02%-31.85M
43.00%-5.66M
8.46%-6.95M
0.51%-9.75M
-23.50%-9.49M
-24.27%-35M
-112.75%-9.93M
Investing cash flow
Cash flow from continuing investing activities
585.42%233K
300.00%14K
200.00%11K
-103.21%-66K
0
30.43%-48K
-100.33%-7K
-11K
-93.92%2.06M
-20K
Net PPE purchase and sale
585.42%233K
300.00%14K
200.00%11K
25.84%-66K
--0
30.43%-48K
---7K
---11K
---89K
---20K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--2.15M
--0
Cash from discontinued investing activities
Investing cash flow
585.42%233K
300.00%14K
200.00%11K
-103.21%-66K
--0
30.43%-48K
-100.33%-7K
---11K
-93.92%2.06M
---20K
Financing cash flow
Cash flow from continuing financing activities
144.67%3.67M
1.43M
-207.14%-7.5M
-82.65%8.81M
295.00%312K
-55.29%1.5M
0
454.68%7M
1,577.25%50.79M
87.22%-160K
Net issuance payments of debt
---220K
--0
---7.5M
--0
--0
--0
--0
--0
112.97%491K
97.12%-36K
Net common stock issuance
--3.46M
----
----
--0
--0
--0
----
----
--47.72M
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-67.61%23K
--0
Net other financing activities
----
----
----
244.76%8.81M
351.61%312K
382.32%1.5M
--0
178.66%7M
822.74%2.56M
-4,033.33%-124K
Cash from discontinued financing activities
Financing cash flow
144.67%3.67M
--1.43M
-207.14%-7.5M
-82.65%8.81M
295.00%312K
-55.29%1.5M
--0
454.68%7M
1,577.25%50.79M
87.22%-160K
Net cash flow
Beginning cash position
-85.02%4.54M
-87.11%5.17M
-54.27%19.47M
72.17%42.57M
-52.89%24.82M
-46.80%30.31M
118.92%40.07M
72.17%42.57M
9.71%24.72M
71.90%52.68M
Current changes in cash
108.25%453K
93.60%-624K
-471.66%-14.3M
-229.46%-23.1M
47.10%-5.35M
-27.71%-5.49M
-125.22%-9.75M
61.05%-2.5M
715.49%17.84M
-70.79%-10.11M
End cash Position
-79.88%4.99M
-85.02%4.54M
-87.11%5.17M
-54.27%19.47M
-54.27%19.47M
-52.89%24.82M
-46.80%30.31M
118.92%40.07M
72.17%42.57M
72.17%42.57M
Free cash flow
50.67%-3.45M
78.82%-2.07M
28.29%-6.81M
9.06%-31.91M
43.11%-5.66M
8.66%-6.99M
0.44%-9.75M
-23.64%-9.5M
-24.58%-35.09M
-113.17%-9.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.33%-3.45M78.80%-2.07M28.21%-6.81M9.02%-31.85M43.00%-5.66M8.46%-6.95M0.51%-9.75M-23.50%-9.49M-24.27%-35M-112.75%-9.93M
Net income from continuing operations 52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M70.55%-10.62M-33.66%-11.62M-92.98%-66.73M-97.32%-12.09M
Operating gains losses -890.00%-495K103.85%4K55.19%419K109.87%45K---71K90.74%-50K---104K--270K---456K--0
Depreciation and amortization -0.53%188K42.31%185K-6.06%186K-27.60%695K-11.88%178K-32.26%189K-60.73%130K33.78%198K68.13%960K38.36%202K
Other non cash items 102.16%281K-64.93%47K-3.23%120K-97.55%541K18.03%144K54.44%139K-99.38%134K12.73%124K3,823.09%22.09M-2.40%122K
Change In working capital 41.86%-250K4,430.30%1.43M-409.92%-1.91M-268.75%-118K-214.89%-270K-276.23%-430K-171.74%-33K210.41%615K99.06%-32K352.69%235K
-Change in prepaid assets -51.76%206K-50.44%397K50.64%-577K-56.70%252K493.88%193K-40.28%427K113.03%801K-154.13%-1.17M122.14%582K-112.28%-49K
-Change in payables and accrued expense 59.77%-278K265.62%1.21M-158.96%-1.16M13.49%244K-164.76%-294K-201.75%-691K-1,522.22%-730K5,497.14%1.96M106.80%215K225.41%454K
-Change in other current liabilities -7.23%-178K-70.19%-177K0.57%-174K25.93%-614K0.59%-169K31.40%-166K63.51%-104K-32.58%-175K-65.14%-829K-30.77%-170K
Cash from discontinued investing activities
Operating cash flow 50.33%-3.45M78.80%-2.07M28.21%-6.81M9.02%-31.85M43.00%-5.66M8.46%-6.95M0.51%-9.75M-23.50%-9.49M-24.27%-35M-112.75%-9.93M
Investing cash flow
Cash flow from continuing investing activities 585.42%233K300.00%14K200.00%11K-103.21%-66K030.43%-48K-100.33%-7K-11K-93.92%2.06M-20K
Net PPE purchase and sale 585.42%233K300.00%14K200.00%11K25.84%-66K--030.43%-48K---7K---11K---89K---20K
Net business purchase and sale --------------0------------------2.15M--0
Cash from discontinued investing activities
Investing cash flow 585.42%233K300.00%14K200.00%11K-103.21%-66K--030.43%-48K-100.33%-7K---11K-93.92%2.06M---20K
Financing cash flow
Cash flow from continuing financing activities 144.67%3.67M1.43M-207.14%-7.5M-82.65%8.81M295.00%312K-55.29%1.5M0454.68%7M1,577.25%50.79M87.22%-160K
Net issuance payments of debt ---220K--0---7.5M--0--0--0--0--0112.97%491K97.12%-36K
Net common stock issuance --3.46M----------0--0--0----------47.72M--0
Proceeds from stock option exercised by employees --------------0-----------------67.61%23K--0
Net other financing activities ------------244.76%8.81M351.61%312K382.32%1.5M--0178.66%7M822.74%2.56M-4,033.33%-124K
Cash from discontinued financing activities
Financing cash flow 144.67%3.67M--1.43M-207.14%-7.5M-82.65%8.81M295.00%312K-55.29%1.5M--0454.68%7M1,577.25%50.79M87.22%-160K
Net cash flow
Beginning cash position -85.02%4.54M-87.11%5.17M-54.27%19.47M72.17%42.57M-52.89%24.82M-46.80%30.31M118.92%40.07M72.17%42.57M9.71%24.72M71.90%52.68M
Current changes in cash 108.25%453K93.60%-624K-471.66%-14.3M-229.46%-23.1M47.10%-5.35M-27.71%-5.49M-125.22%-9.75M61.05%-2.5M715.49%17.84M-70.79%-10.11M
End cash Position -79.88%4.99M-85.02%4.54M-87.11%5.17M-54.27%19.47M-54.27%19.47M-52.89%24.82M-46.80%30.31M118.92%40.07M72.17%42.57M72.17%42.57M
Free cash flow 50.67%-3.45M78.82%-2.07M28.29%-6.81M9.06%-31.91M43.11%-5.66M8.66%-6.99M0.44%-9.75M-23.64%-9.5M-24.58%-35.09M-113.17%-9.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg